Globus Medical Sponsors NASS 2018, Hosts In-Booth Presentations on ExcelsiusGPS®
Globus Medical’s participation at NASS includes two in-booth presentations from surgeons currently using ExcelsiusGPS® that highlight the versatility of robotic guidance and navigation in both minimally invasive and complex deformity procedures. In addition to the presentations, meeting attendees have the opportunity to discuss advancements in robotic surgery and experience the company’s most recent product innovations.
“As leaders in the musculoskeletal device industry, we are committed to supporting the research, education, and development of medical advancements through robotic spine surgery,” said Chief Executive Officer
Globus welcomes NASS attendees to case presentations in Booth #1411.
Minimally Invasive Cases with ExcelsiusGPS®
Sabino D’Agostino, MD
Complex and Deformity Cases with ExcelsiusGPS®
Themistocles Protopsaltis, MD
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to successfully integrate the operations of Nemaris and retain key employees, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the
Source: Globus Medical